Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective

According to the results of FLOT4 trial, perioperative FLOT chemotherapy improved overall survival (OS) in locally advanced, resectable esophagogastric adenocarcinoma (EGA) compared to perioperative ECF/ECX. We report real-life data 10 years after introduction of perioperative FLOT at our institutio...

Full description

Saved in:
Bibliographic Details
Main Authors: Peters, Leila (Author) , Crnovrsanin, Nerma (Author) , Nienhüser, Henrik (Author) , Jung, Jin-On (Author) , Schiefer, Sabine (Author) , Haag, Georg Martin (Author) , Bruckner, Thomas (Author) , Schneider, Martin (Author) , Müller, Beat P. (Author) , Büchler, Markus W. (Author) , Schmidt, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 10 February 2023
In: Langenbeck's archives of surgery
Year: 2023, Volume: 408, Pages: 1-15
ISSN:1435-2451
DOI:10.1007/s00423-023-02822-7
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00423-023-02822-7
Get full text
Author Notes:Leila Sisic, Nerma Crnovrsanin, Henrik Nienhueser, Jin-On Jung, Sabine Schiefer, Georg Martin Haag, Thomas Bruckner, Martin Schneider, Beat P. Müller-Stich, Markus W. Büchler, Thomas Schmidt
Description
Summary:According to the results of FLOT4 trial, perioperative FLOT chemotherapy improved overall survival (OS) in locally advanced, resectable esophagogastric adenocarcinoma (EGA) compared to perioperative ECF/ECX. We report real-life data 10 years after introduction of perioperative FLOT at our institution.
Item Description:Gesehen am 17.03.2023
Physical Description:Online Resource
ISSN:1435-2451
DOI:10.1007/s00423-023-02822-7